Issue link: http://osercommunicationsgroup.uberflip.com/i/1013207
Chain Drugstore Daily 2 7 Monday, August 27, 2018 Alendronate Sodium Oral Solution NDC# 51224-301-10 Why choose Alendronate Oral Solution? It's the only retail centered, non- injectable generic alternative to the tablet. It's the only generic Alendronate Oral Solution on the market. It's the only generic Alendronate that's not a tablet. It's covered by Medicaid, most Medicare and most private insurance policies. It is stocked and available at your preferred wholesaler or available for direct ship- ment. The minimum order quantity has been reduced to one unit for direct orders. In 2013, TAGI Pharma, Inc., announced the launch of its Alendronate Sodium Oral Solution, 70mg/75mL, once weekly, bone resorption suppression agent in the United States and its territo- ries, possessions and protectorates. This FDA approved oral solution is the sole source generic alternative to Merck & Co., Inc.'s FOSAMAX ® (Alendronate Sodium) Oral Solution and is indicated for the treatment of osteoporosis in post- menopausal women. In postmenopausal women, Alendronate increases bone mass and reduces the incidence of frac- tures, including those of the hip and spine (vertebral compression fractures), and as treatment to increase bone mass in men with osteoporosis. Contraindications: Abnormalities of the esophagus which delay esophageal emptying such as stric- ture or achalasia; inability to stand or sit upright for at least 30 minutes; do not administer Alendronate Sodium Oral Solution to patients at increased risk of aspiration; hypocalcemia; hypersensitivi- ty to any component of this product; hyper- sensitivity reactions including urticaria and angioedema have been reported. " A l e n d r o n a t e Oral Solution repre- sents a key step for- ward in the implementation of TAGI Pharma's business plan to bring differen- tiated products to the marketplace," said Kenny Harrington, Vice President of Sales and Marketing. "Alendronate Sodium Oral Solution addresses unmet needs in the market for a liquid Alendronate product, and complements the TAGI strategy to provide unique products to underserved customers." "TAGI Pharma, Inc. was estab- lished to target the generic retail mar- ket," said Kenny Harrington, "and our product selection for TAGI Pharma is focused on higher barriers to entry and limited competition where there are mar- ket expansion oppor- tunities in the retail market, as well as the non-retail sector currently being serv- iced by Precision Dose, our parent company. Keys to our success have been a thorough understanding of the markets we compete in and identification of profitable product opportunities that provide an added value to our cus- tomers, with a foundation always grounded in product quality and high service level performance." Visit TAGI Pharma at booth #3311. Visit www.tagipharma.com to view Alendronate Sodium Oral Solution full prescribing information, which includes indications for use and additional impor- tant safety information. Uniweb OTC Display Fixtures Industry studies have shown that over- the-counter sales account for 30 percent of a store's profit margin, while behind the RX counter is only 5 percent. Let Uniweb help you create a complimentary and inviting climate for the customers to enjoy, maximizing those profits. Customer-centric over-the-counter plan- ners must focus on keeping your products organized and easily accessible. Aesthetically appealing shelves and fix- tures must be marketed to grab the atten- tion of those traveling up and down the aisles. Functional categorization and sim- plicity in navigation for your OTC prod- ucts using Uniweb equipment will help you achieve these goals. Uniweb crafts unique custom-made shelving designed to fit your specific OTC needs. The all-steel back panels consist of continuous horizontal chan- nels, vertically spaced every inch. This allows for greater utilization of the dis- play surface, creating unrestricted mer- chandising or storage space. These back panels are the mainstay component of the perimeter wall panels, center aisles gon- dolas, end caps, locking display cases and rolling display units. OTC product facings are increased by a minimum of 17 to 25 percent, and in some cases up to 50 percent. This extreme capitalization on space results in greater profits for retailers. Combine these tight ribbed pan- els with the extensive array of shelving options for the optimal shopping experi- ence. With Uniweb, your merchandiser will need minimum space while Uniweb delivers maximum display. The density of the Uniweb panel's channels means no obnoxious gaps or wasted space. Uniweb makes a variety of shelving and accessory options for ideal OTC merchandise placement. Use the small- er shelves for small prod- ucts on the top of the dis- play and graduate down the unit to larger shelves for the bulkier/heavier items. Moreover, with Uniweb you can shelve and peg, side by side. With such an immense amount of OTC products available, Uniweb pro- vides the ideal sales tool in displaying and organizing the product for peak cus- tomer appeal and easy "shopability." Plus, added facings create ease of cus- tomer viewing and selection of the huge selection of products. Refresh the visual appeal by using Rolling Gondolas to change out seasonal OTC items during cold and flu, allergy or sunscreen seasons. These lighter-weight mobile gondolas make the relocation quick and effortless. For high- end items, electronics, or any- thing needing to be secured, Uniweb creates locking display cases for loss prevention. Highlight your product within the cases by incorporating millwork, lighting and glass for a sleek vibrant look. Add custom millwork frames or accessories to these units to vanquish the traditional sterile RX environment and create a warm, inviting atmosphere. Imagine the goal; Uniweb will help you bring it to reality. Give Uniweb your challenges today. Visit Uniweb at booth #1237. For more information, call 800.486.4932 or go to www.uniwebinc.com. Prasco Builds on Authorized Generics Leadership Prasco is a worldwide leader in Authorized Generics. An Authorized Generic (AG) is the brand prescription product sold in private label packaging at generic prices. Unlike an ANDA generic, it is identical to the brand drug, contain- ing the exact same active and inactive ingredients. Prasco AGs increase compe- tition and provide patients with brand- quality products at more affordable prices. In 2018, Prasco partnered with AMAG Pharmaceuticals on the launch of an Authorized Generic version of the intramuscular version of Makena ® (hydroxyprogesterone caproate injec- tion), adding to Prasco's growing portfo- lio of specialty products. Specialty prod- ucts currently make up over half of the single source brand market in terms of dollars and this category continues to grow at near double digit rates year over year. Prasco's expertise and presence in this space makes it well-positioned to help partners extend the lifecycle of their products through the launch of an Authorized Generic. Adding to its latest Authorized Generic launch, Prasco has a blockbuster lineup of products expected to launch in the coming year. Prasco believes that its 2018 AG pipeline repre- sents a significant amount of brand drug dollars facing potential generic competition. Based on the value that they bring to their brand partners, the landscape for Authorized Generics looks stronger than ever. Comprehensive Distribution Services Prasco is committed to working with cus- tomers and partners to meet all of their business objectives through comprehen- sive distribution services. Prasco pro- vides stable product supply, supply chain metrics and responsive, flexible distribution capabilities: expand- ed cold chain capabilities; orders ship within 24 hours; 99.9 per- cent shipping accuracy; and industry leading reliability. Prasco is excited about what it has to offer partners, customers and patients. The future always starts with innovation, and when Prasco's partners are the world's most innovative in phar- maceutical research and development, the future looks brighter than ever. For more information, visit booth #1013 or go to www.prasco.com. Makena ® is a registered trademark of AMAG Pharmaceuticals, Inc. One Brand Plus One Brand Can Equal Three Customers By John Owen, Chief Executive Officer, Green Chile Foods Company There is a place for private label and it will always be an important part of any retail- er's strategy. However, c-store and CPG brands can leverage one another for mutual growth where one plus one can equal three. C-store retailers and consumer pack- aged goods companies should leverage one another for mutual benefit and growth. For a brand to carry serious weight in a category, it needs to be thought of as an "authority." Ranked No. 1 for growth rate among the top 10 brands in the con- venience channel, the Green Chile brand is fast becoming an authority on south- western flavors. Green Chile burritos are made using authentic ingredients cus- tomers can see and taste. Bold peppers, real Monterey Jack and cheddar cheeses, and quality proteins are carefully rolled up and layered with signature salsas for an exceptional taste experience. Consumers expect to be engaged, edu- cated, entertained. The best c-store retailers offer an assortment of the strongest and most interesting brands. Providing an exceptional shopping environment is the retailer's most important job. When retail- ers and consumer packaged goods compa- nies stick to what they do best – their areas of authority – this combined strength can multiply customer counts and improve profitability. One plus one can equal three. For more information, go to www.green chilefoods.com or call 952.666.2993.